Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

The Journal of Infectious Diseases
Peter F WrightBarney S Graham

Abstract

The relationships between host factors, viral shedding, illness severity, and antibody response in respiratory syncytial virus (RSV)-induced bronchiolitis are poorly defined. These relationships were prospectively evaluated in 77 infants hospitalized with RSV bronchiolitis in multicenter, double-blind, placebo-controlled trials of RSV immunoglobulin therapy. Severity of illness was influenced by age and host risk factors but was not influenced by RSV neutralizing antibody titer or by the amount of virus in nasal secretions at enrollment. Virus recovery in nasal secretions was variable but was highest at enrollment. Viral shedding was not influenced by primary diagnosis, antibody titer, age, or duration of acute respiratory illness before enrollment. In intubated patients, the amounts of virus recovered in nasal secretions and endotracheal aspirates were highly correlated. A serum neutralizing antibody response was seen in 64% of subjects who received placebo. The response was not influenced by age, primary diagnosis, amount of virus recovered, or severity of illness but was suppressed by preexisting antibody.

Citations

Mar 13, 2012·Medical Microbiology and Immunology·Carolina ScagnolariGuido Antonelli
Apr 12, 2013·Clinical Reviews in Allergy & Immunology·Andrea T BorchersLaurel J Gershwin
Nov 1, 2013·The Journal of Infection·Rosa Rodriguez, Octavio Ramilo
Aug 16, 2008·The Journal of Infectious Diseases·Joshua J ShinoffRuth A Karron
Sep 18, 2009·The Journal of Infectious Diseases·Coley B DuncanAnn R Falsey
Oct 14, 2005·Pediatric Case Reviews·Howard B Panitch
Apr 3, 2003·The Pediatric Infectious Disease Journal·Hasan S Jafri
Sep 10, 2009·The Pediatric Infectious Disease Journal·Carmen L LarrañagaLuis F Avendaño
Feb 27, 2010·Current Opinion in Pediatrics·Alfin G Vicencio
Oct 12, 2007·Journal of Virology·Peter L Collins, Barney S Graham
Jul 14, 2010·American Journal of Respiratory and Critical Care Medicine·John P DeVincenzoRobert Lambkin-Williams
Jan 26, 2010·BMC Infectious Diseases·Emelda A OkiroD James Nokes
Apr 26, 2014·PLoS Pathogens·Jia MengMartin L Moore
Dec 2, 2005·Emerging Infectious Diseases·Mei-Shang HoJyh-Yuan Yang
Feb 7, 2013·Viruses·Rajeev RudrarajuJulia L Hurwitz
Aug 21, 2013·American Journal of Respiratory and Critical Care Medicine·Hong Guo-ParkeUltan F Power
Feb 24, 2016·Human Vaccines & Immunotherapeutics·Susanna EspositoNicola Principi
Jan 7, 2016·The New England Journal of Medicine·H Cody Meissner
Oct 10, 2008·Diagnostic Microbiology and Infectious Disease·Emily T MartinJanet A Englund
Sep 15, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jane KuypersRhoda Morrow
Nov 21, 2015·Journal of Medical Virology·Aya TakeyamaMitsuaki Hosoya
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Federico Martinón-Torres
Apr 30, 2015·The Journal of Infection·Asuncion Mejias, Octavio Ramilo
May 24, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Sandra AmpueroCarmen E Larrañaga
Mar 26, 2015·Immunotherapy·Bert SchepensXavier Saelens
Jul 6, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Vivian LuchsingerCarmen E Larrañaga
Jan 3, 2015·The Journal of Clinical Investigation·Mauricio T CaballeroFernando P Polack
Aug 29, 2014·Paediatric Respiratory Reviews·Jérôme O WishauptNico G Hartwig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.